The U.S. Food and Drug Administration issued letters to several companies -- including major pharmacy chains -- this week, warning them against manufacturing or selling unapproved eye products.

The US Food and Drug Administration on Monday sent warning letters to CVS, Walgreens and other companies over manufacturing and marketing of unapproved eye products the agency says could pose a ...

The U.S. Food and Drug Administration issued letters to several companies -- including major pharmacy chains -- this week, warning them against manufacturing or selling unapproved eye products.

The FDA has sent warning letters to two online vendors — US Chem Labs and Helix Chemical Supply — for selling unapproved and misbranded versions of semaglutide and tirzepatide. Federal ...

Sept 12 (Reuters) - The U.S. Food and Drug Administration on Tuesday said it has issued warning letters to eight companies, including pharmacy giants CVS Health Corp and Walgreens Boots Alliance ...

A mail-order pharmacy whose co-founder has repeatedly criticized the Food and Drug Administration on "The Joe Rogan Experience" has been caught up in an embarrassing recall by the US agency, The ...

Empower has been the subject of four warning letters and a less severe "untitled letter" from the FDA going back to 2017, and its pharmacy license was placed on probation in 2023 by the California ...

A mail-order pharmacy whose co-founder has repeatedly criticized the Food and Drug Administration on “The Joe Rogan Experience” has been caught up in an embarrassing recall by the US agency ...

The U.S. Food and Drug Administration issued a warning letter to Optum Infusion Services over unsanitary conditions at one of its locations where it compounds drugs. The FDA inspected an Optum ...

Fagron: FDA Warning Letter Creates New Entry Opportunity. Jan. 08, 2025 10:30 AM ET Fagron NV ... It will acquire CareFirst Specialty Pharmacy in the USA and Injeplast in Brazil.

The US Food and Drug Administration on Monday sent warning letters to CVS, Walgreens and other companies over manufacturing and marketing of unapproved eye products the agency says could pose a ...